GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Stratec SE (OTCPK:SRBZF) » Definitions » Cyclically Adjusted PB Ratio

Stratec SE (Stratec SE) Cyclically Adjusted PB Ratio : 2.54 (As of Jun. 06, 2024)


View and export this data going back to 2011. Start your Free Trial

What is Stratec SE Cyclically Adjusted PB Ratio?

As of today (2024-06-06), Stratec SE's current share price is $72.9551. Stratec SE's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was $28.75. Stratec SE's Cyclically Adjusted PB Ratio for today is 2.54.

The historical rank and industry rank for Stratec SE's Cyclically Adjusted PB Ratio or its related term are showing as below:

SRBZF' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 2.37   Med: 6.88   Max: 12.7
Current: 3.01

During the past years, Stratec SE's highest Cyclically Adjusted PB Ratio was 12.70. The lowest was 2.37. And the median was 6.88.

SRBZF's Cyclically Adjusted PB Ratio is ranked worse than
64.42% of 475 companies
in the Medical Devices & Instruments industry
Industry Median: 2.1 vs SRBZF: 3.01

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Stratec SE's adjusted book value per share data for the three months ended in Mar. 2024 was $20.496. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $28.75 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Stratec SE Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Stratec SE's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stratec SE Cyclically Adjusted PB Ratio Chart

Stratec SE Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.05 11.41 11.34 5.77 2.94

Stratec SE Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.27 4.24 2.89 2.94 2.54

Competitive Comparison of Stratec SE's Cyclically Adjusted PB Ratio

For the Medical Devices subindustry, Stratec SE's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Stratec SE's Cyclically Adjusted PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Stratec SE's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Stratec SE's Cyclically Adjusted PB Ratio falls into.



Stratec SE Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Stratec SE's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=72.9551/28.75
=2.54

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Stratec SE's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Stratec SE's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=20.496/125.0381*125.0381
=20.496

Current CPI (Mar. 2024) = 125.0381.

Stratec SE Quarterly Data

Book Value per Share CPI Adj_Book
201406 11.555 99.543 14.515
201409 11.606 99.823 14.538
201412 11.726 99.543 14.729
201503 11.062 99.717 13.871
201506 11.219 100.417 13.970
201509 11.735 100.417 14.612
201512 11.892 99.717 14.912
201603 0.000 100.017 0.000
201606 12.248 100.717 15.206
201609 12.493 101.017 15.464
201612 12.666 101.217 15.647
201703 13.344 101.417 16.452
201706 13.333 102.117 16.326
201709 14.849 102.717 18.076
201712 15.676 102.617 19.101
201803 16.089 102.917 19.547
201806 13.931 104.017 16.746
201809 14.382 104.718 17.173
201812 14.473 104.217 17.364
201903 14.471 104.217 17.362
201906 13.981 105.718 16.536
201909 13.802 106.018 16.278
201912 14.692 105.818 17.361
202003 14.485 105.718 17.132
202006 14.665 106.618 17.199
202009 15.798 105.818 18.668
202012 17.349 105.518 20.559
202103 17.992 107.518 20.924
202106 18.804 108.486 21.673
202109 19.375 109.435 22.138
202112 19.173 110.384 21.718
202203 19.758 113.968 21.677
202206 17.814 115.760 19.242
202209 17.515 118.818 18.432
202212 19.624 119.345 20.560
202303 20.267 122.402 20.703
202306 19.830 123.140 20.136
202309 19.828 124.195 19.963
202312 20.932 123.773 21.146
202403 20.496 125.038 20.496

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Stratec SE  (OTCPK:SRBZF) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Stratec SE Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Stratec SE's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Stratec SE (Stratec SE) Business Description

Traded in Other Exchanges
Address
Gewerbestrasse 37, Birkenfeld, RP, DEU, 75217
Stratec SE designs and manufactures automated analyzer systems for laboratory data management and solutions for molecular diagnostic sample preparation and stabilization. Its business segments are Instrumentation, Diatron and Smart Consumables. Its Instrumentation segment is engaged in designing and manufacturing automated analyzer systems for clinical diagnostics and biotechnology customers. The Diatron segment comprises the business with systems, system components, consumables, and tests in the low throughput hematology and clinical chemistry segment. Its Smart Consumables segment is engaged in developing and selling scientific materials, such as nucleic acid purification. The company generates maximum revenue from the Instrumentation segment.

Stratec SE (Stratec SE) Headlines

From GuruFocus